Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Chronic Pain

In brief

This study will evaluate whether crushed EMBEDA capsules induce clinical opiate withdrawal signs and symptoms in opioid-dependent patients with chronic non-cancer pain who are stabilized on EMBEDA.

Key facts

Study ID
NCT01100437
Run by
Pfizer
People needed
14
Starts
2010-04-01
Expected to finish
2011-03-01
Last updated by the study team
2012-07-13

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.